Environmental detection of antimicrobial resistance has expanded rapidly, but many programs still treat detection of antibiotic resistance genes (ARGs) or resistant bacteria as the primary endpoint. As a result, outputs are often only weakly linked to antibiotic exposure conditions and remain difficult to compare, interpret, and use consistently for follow-up decisions. This review examines how detection of antibiotics and ARG/ARB can be standardized for regulatory interpretation and qualitative